Procyon Advisors, LLC Amicus Therapeutics, Inc. Transaction History
Procyon Advisors, LLC
- $1.61 Billion
- Q1 2025
A detailed history of Procyon Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 42,576 shares of FOLD stock, worth $286,110. This represents 0.02% of its overall portfolio holdings.
Number of Shares
42,576
Previous 24,392
74.55%
Holding current value
$286,110
Previous $229,000
56.33%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
308Shares Held
283MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$197 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$164 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$163 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$156 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$105 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.88B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...